Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT06865079

Public ClinicalTrials.gov record NCT06865079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 4:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Severe Tibio- Femoral Osteoarthritis of the Knee

Study identification

NCT ID
NCT06865079
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
OrthoTrophix, Inc
Industry
Enrollment
270 participants

Conditions and interventions

Interventions

  • PBS Other
  • TPX-100 200mg, Once weekly for 4 weeks Drug

Other · Drug

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2025
Primary completion
Mar 24, 2027
Completion
Apr 14, 2027
Last update posted
Feb 16, 2026

2025 – 2027

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
Elite Clinical Network Scottsdale Arizona 85260
Noble Clinical Research Tucson Arizona 85704
Legent Orthopedic Hospital Carrolton California 75006
Medvin Clinical Research Covina California 91722
CORE Orthopaedic Medical Center Encinitas California 92024
Marvel Clinical Research (Elite Clinical Network) Huntington Beach California 92647
Medvin Clinical Research Center Riverside California 92518
Medvin Clinical Research Center Tujunga California 91042
Medvin Clinical Research Center Whittier California 90602
K2 Medical Research Maitland Florida 32751
Wellness Research Center Miami Florida 33135
Well Pharma Medical Research Miami Florida 33173
Las Mercedes Medical Research Miami Florida 33196
Drug Studies of America Marietta Georgia 30060
AMR Kansas City Kansas City Kansas 64114
University of Kansas Medical Center Kansas City Kansas 66160
AMR Lexington Lexington Kentucky 40509
Accurate Clinical Research Inc. Lake Charles Louisiana 70605
Mayo Clinic (Rochester) Rochester Minnesota 55905
Las Vegas Clinical Trials North Las Vegas Nevada 89030
Albuquerque Clinical Trials Albuquerque New Mexico 87102
Center for Clinical Research Winston-Salem North Carolina 27103
Hightower Clinical Oklahoma City Oklahoma 73102
University Orthopedics Center Altoona Pennsylvania 16602
University Orthopedics Center State College Pennsylvania 16801
AMR Knoxville Knoxville Tennessee 37909
Accurate Clinical Research, LLC Baytown Texas 77521
Texas Orthopedic Specialist Bedford Texas 76021
First Surgical Hospital Bellaire Texas 77401
Accurate Clinical Research Houston Texas 77089
Endeavor Clinical Trials San Antonio Texas 78229
CenExel Salt Lake City Utah 84107
Wasatch Clinical Research Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06865079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06865079 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →